Use cefradine capsules to reduce inflammation of episiotomy wounds

Everyone should be familiar with Cefuroxime Capsules. As everyone knows, cefuroxime capsules are an anti-inflammatory drug. But similarly, not everyone can use cefuroxime capsules. Because some friends have adverse reactions to cefuroxime capsules. So, do you know if cefuroxime capsules can be used to reduce inflammation in episiotomy wounds? It depends on what the doctor says.

Cefradine Capsules: The contents of this product are white to off-white or light yellow powder or granules. It is suitable for respiratory tract infections such as acute pharyngitis, tonsillitis, otitis media, bronchitis and pneumonia, urinary and reproductive tract infections, and skin and soft tissue infections caused by sensitive bacteria. This product is an oral preparation and should not be used for serious infections. This product is contraindicated in patients who are allergic to cephalosporins or have a history of anaphylactic shock or immediate reaction to penicillin.

oral. Common dosage for adults: 0.25-0.5 g at a time, once every 6 hours. For more serious infections, the dosage can be increased to 1 g at a time, but the total daily dosage should not exceed 4 g. Usual dosage for children: 6.25-12.5 mg/kg based on body weight, once every 6 hours. During treatment, regardless of the patient's age and weight, the maximum dose of cefradine that can be taken is 1g/time, once every 6 hours. As with other antimicrobial treatments, cefradine treatment should be continued for at least 48-72 hours after the patient's symptoms of infection have resolved or evidence of bacterial clearance has been obtained. When treating infections caused by group A B-hemolytic streptococci, treatment for at least 10 days is recommended to prevent the development of rheumatic fever or glomerulonephritis. When treating chronic urinary tract infections, it is necessary to treat during the treatment period.

1. Before using this product, the patient must be asked in detail about the history of allergies to cephalosporins, penicillins and other drugs. Patients with a history of anaphylactic shock to penicillins should not use this product. When other patients use this product, they must be aware that the chance of cross-allergic reactions between cephalosporins and penicillins is about 5% to 7%, and it needs to be used with caution under close observation. If an allergic reaction occurs, stop taking the medication immediately. If anaphylactic shock occurs, immediate rescue is required on the spot, including keeping the airway open, oxygen inhalation, and the use of epinephrine and glucocorticoids.

2. This product is mainly excreted through the kidneys. Patients with impaired renal function should reduce the dosage or extend the dosing interval.

3. Patients using this product may experience false positive reactions when measuring urine sugar using the copper sulfate method.